escribed are agents which inhibit microRNA-144 (miR-144) for use in treating or preventing a liver disease and/or liver condition in which oxidative stress is a contributory factor in a subject, methods for identifying a subject who has, or who is at risk of developing, said liver disease and/or liver condition, methods of predicting the response of a subject with said liver disease and/or liver condition to an agent which inhibits miR-144, methods of diagnosing said liver disease and/or liver condition, pharmaceutical compositions and kits.
MEDICAL USES, METHODS AND USES
Azzimato V
;
2020-01-01
Abstract
escribed are agents which inhibit microRNA-144 (miR-144) for use in treating or preventing a liver disease and/or liver condition in which oxidative stress is a contributory factor in a subject, methods for identifying a subject who has, or who is at risk of developing, said liver disease and/or liver condition, methods of predicting the response of a subject with said liver disease and/or liver condition to an agent which inhibits miR-144, methods of diagnosing said liver disease and/or liver condition, pharmaceutical compositions and kits.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
